Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:15 PM
Ignite Modification Date:
2025-12-24 @ 9:15 PM
NCT ID:
NCT02068404
Eligibility Criteria:
Inclusion Criteria:
* Pregnant women under nifedipine treatment for acute threatened preterm labour
* Hospitalization for this condition in the maternity of the University Hospital of Lausanne (CHUV)
* Gestational age of 20-34 weeks
* Signed informed consent
Exclusion Criteria:
* Patient \< 18 years
* Contraindication to tocolysis for clinical reasons (e.g. severe pre-eclampsia, chorioamnionitis, placental anomaly, letal fetal anomaly, important intrauterine growth restriction) or current labour
* Contraindication to nifedipine
* Severe renal or hepatic impairment
* Fever \> 37.5°C
* Incapacity of communication
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT02068404
Study Brief:
Protocol Section:
NCT02068404